| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-09 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |